Published in Neuroscience on August 27, 2011
Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease. Neuron (2014) 1.72
Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease. Nat Med (2014) 1.67
A restricted population of CB1 cannabinoid receptors with neuroprotective activity. Proc Natl Acad Sci U S A (2014) 1.61
Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models. Nat Commun (2016) 1.42
Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron (2012) 1.38
Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease. PLoS One (2012) 1.31
Huntington's disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci (2013) 1.31
Striatal microcircuitry and movement disorders. Trends Neurosci (2012) 1.22
Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models. J Neurosci (2013) 1.04
Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front Neurosci (2013) 0.99
Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics (2012) 0.98
Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons. BMC Genomics (2012) 0.96
Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Cell Biochem (2012) 0.92
Preserving cortico-striatal function: deep brain stimulation in Huntington's disease. Front Syst Neurosci (2015) 0.91
Hippocampal neurogenesis, cognitive deficits and affective disorder in Huntington's disease. Neural Plast (2012) 0.91
Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease. Chem Biol (2013) 0.90
Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits. J Neurosci (2014) 0.87
Unique biology of gliomas: challenges and opportunities. Trends Neurosci (2012) 0.87
Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation. Neurosci Biobehav Rev (2015) 0.85
Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice. Proc Natl Acad Sci U S A (2012) 0.85
Distinct neurogenomic states in basal ganglia subregions relate differently to singing behavior in songbirds. PLoS Comput Biol (2012) 0.85
The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease. Hum Mol Genet (2014) 0.85
Memory and synaptic deficits in Hip14/DHHC17 knockout mice. Proc Natl Acad Sci U S A (2013) 0.85
Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin. J Biol Chem (2013) 0.84
The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int (2014) 0.84
A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity. Elife (2015) 0.83
A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation. Front Neurol (2013) 0.83
Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease. J Neurophysiol (2015) 0.83
Striatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington disease. PLoS One (2014) 0.82
Synaptic dysfunction and septin protein family members in neurodegenerative diseases. Mol Neurodegener (2015) 0.82
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Front Cell Neurosci (2014) 0.81
Corticostriatal synaptic adaptations in Huntington's disease. Curr Opin Neurobiol (2015) 0.80
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease. J Neurochem (2012) 0.80
Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice. Neurobiol Dis (2014) 0.78
AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease. Gene Ther (2015) 0.78
Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. J Huntingtons Dis (2012) 0.78
Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease. J Physiol (2015) 0.78
The unfolded protein response and its potential role in Huntington ´s disease elucidated by a systems biology approach. F1000Res (2015) 0.77
Neurochemical correlates of caudate atrophy in Huntington's disease. Mov Disord (2014) 0.77
Neural correlates of unpredictability in behavioral patterns of wild-type and R6/2 mice. Commun Integr Biol (2012) 0.77
Examination of Huntington's disease in a Chinese family. Neural Regen Res (2014) 0.77
Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice. Neurochem Int (2014) 0.77
Plants and phytochemicals for Huntington's disease. Pharmacogn Rev (2013) 0.77
Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity. BMC Neurosci (2015) 0.76
Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease. Front Cell Neurosci (2016) 0.76
Hyperkinetic disorders and loss of synaptic downscaling. Nat Neurosci (2016) 0.76
Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets. Front Neurosci (2017) 0.76
Sudden death due to paralysis and synaptic and behavioral deficits when Hip14/Zdhhc17 is deleted in adult mice. BMC Biol (2016) 0.75
Life and death rest on a bivalent chromatin state. Nat Neurosci (2016) 0.75
Influence of cortical synaptic input on striatal neuronal dendritic arborization and sensitivity to excitotoxicity in corticostriatal coculture. J Neurophysiol (2016) 0.75
Huntington's disease: easing the NMDAR traffic jam. Nat Med (2013) 0.75
Deep Brain Stimulation in Huntington's Disease-Preliminary Evidence on Pathophysiology, Efficacy and Safety. Brain Sci (2016) 0.75
Impaired striatal function in Huntington's disease is due to aberrant p75NTR signaling. Rare Dis (2014) 0.75
Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation. J Huntingtons Dis (2016) 0.75
Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease. Antioxid Redox Signal (2013) 0.75
Clinical and genetic investigation of a Brazilian family with Huntington's disease. Funct Neurol (2016) 0.75
Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2017) 0.75
Model-Based Magnetization Transfer Imaging Markers to Characterize Patients and Asymptomatic Gene Carriers in Huntington's Disease. Front Neurol (2017) 0.75
Echogenicity of basal ganglia structures in different Huntington's disease phenotypes. J Neural Transm (Vienna) (2014) 0.75
Differential Alteration in Expression of Striatal GABAAR Subunits in Mouse Models of Huntington's Disease. Front Mol Neurosci (2017) 0.75
A synaptic model of memory: long-term potentiation in the hippocampus. Nature (1993) 29.13
The glutamate receptor ion channels. Pharmacol Rev (1999) 15.06
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (1997) 11.53
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci (2005) 9.17
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (1990) 8.07
Oxidative stress, glutamate, and neurodegenerative disorders. Science (1993) 7.96
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci (2002) 7.57
Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med (1994) 6.77
Huntington disease. J Neuropathol Exp Neurol (1998) 6.54
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell (2000) 6.45
PSD-95 involvement in maturation of excitatory synapses. Science (2000) 6.15
Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci (2003) 5.83
Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci (2010) 5.27
Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol (1987) 5.22
Role of distinct NMDA receptor subtypes at central synapses. Sci STKE (2004) 4.99
Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci (1999) 4.56
The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci (1999) 4.37
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci (2002) 4.15
Synaptic strength regulated by palmitate cycling on PSD-95. Cell (2002) 4.15
Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet (2003) 4.07
Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci (2008) 4.04
Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet (2001) 3.84
Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. Neuron (2005) 3.72
Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet (1997) 3.64
Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov (2006) 3.58
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci (2008) 3.54
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50
NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci (2007) 3.44
Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron (2003) 3.25
Subunit-specific NMDA receptor trafficking to synapses. Neuron (2002) 3.16
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron (2002) 3.15
Synaptic organisation of the basal ganglia. J Anat (2000) 3.12
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci (1992) 3.10
Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol (2003) 3.08
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet (2000) 3.07
Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron (2004) 3.04
Glutamate neurotoxicity in cortical cell culture. J Neurosci (1987) 2.98
Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci (1996) 2.89
The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci (1992) 2.89
DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell (2010) 2.87
Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci (1990) 2.83
Molecular determinants of NMDA receptor internalization. Nat Neurosci (2001) 2.79
Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science (1983) 2.79
Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A (1988) 2.78
Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet (2007) 2.77
Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology (2003) 2.73
The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron (2005) 2.68
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum Mol Genet (2000) 2.67
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med (2009) 2.66
Synaptic targeting of the postsynaptic density protein PSD-95 mediated by lipid and protein motifs. Neuron (1999) 2.64
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol (2005) 2.57
Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. J Neurosci (2008) 2.50
GABAergic microcircuits in the neostriatum. Trends Neurosci (2004) 2.47
Huntington's disease: from pathology and genetics to potential therapies. Biochem J (2008) 2.41
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain (2008) 2.40
Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron (2010) 2.36
The thalamostriatal system: a highly specific network of the basal ganglia circuitry. Trends Neurosci (2004) 2.33
NMDA receptor surface mobility depends on NR2A-2B subunits. Proc Natl Acad Sci U S A (2006) 2.31
Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience (2008) 2.31
Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci (2008) 2.29
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature (1986) 2.29
Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci (1993) 2.27
Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons. J Neurophysiol (2005) 2.27
Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons. J Physiol (2006) 2.27
N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog Neurobiol (2006) 2.25
Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. Mov Disord (2006) 2.23
Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium (2003) 2.21
Regulation of NMDA receptors by phosphorylation. Neuropharmacology (2007) 2.20
Distinct roles of GABAergic interneurons in the regulation of striatal output pathways. J Neurosci (2010) 2.20
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Role of brain-derived neurotrophic factor in Huntington's disease. Prog Neurobiol (2007) 2.17
Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 2.16
Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection. J Neurosci (2005) 2.16
Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A (2005) 2.15
The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci (1987) 2.15
Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci U S A (1998) 2.14
Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron (2005) 2.11
Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature (1976) 2.08
Recurrent connection patterns of corticostriatal pyramidal cells in frontal cortex. J Neurosci (2006) 2.05
Subunit-specific regulation of NMDA receptor endocytosis. J Neurosci (2004) 2.04
Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci U S A (2000) 2.00
Bilateral globus pallidus stimulation for Huntington's disease. Ann Neurol (2004) 2.00
The corticostriatal pathway in Huntington's disease. Prog Neurobiol (2006) 1.99
Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci (1990) 1.96
Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron (2002) 1.95
Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology (2005) 1.95
Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci (1990) 1.94
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol (2001) 1.91
Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med (1990) 1.89
Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience (2008) 1.89
Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci (2003) 1.88
Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology (2006) 1.88
Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. J Neurosci (2009) 1.87
A conserved DNA sequence in homoeotic genes of the Drosophila Antennapedia and bithorax complexes. Nature (1984) 6.62
Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun (1978) 3.12
Synergistic activation and repression of transcription by Drosophila homeobox proteins. Cell (1989) 3.01
Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet (2000) 2.95
Are neostriatal dopamine receptors co-localized? Trends Neurosci (1993) 2.28
Plain film diagnosis of the acute abdomen. Emerg Med Clin North Am (1985) 2.11
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci U S A (1993) 2.08
Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev Neurosci (1998) 2.01
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. J Neurophysiol (2001) 1.91
Congenital esophageal stenosis in adults. Am J Gastroenterol (2000) 1.77
Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience (2008) 1.76
NMDA receptor function in mouse models of Huntington disease. J Neurosci Res (2001) 1.76
Portal venous gas as a complication of ERCP and endoscopic sphincterotomy. Am J Gastroenterol (1995) 1.65
Killian-Jamieson diverticula: radiographic findings in 16 patients. AJR Am J Roentgenol (2001) 1.56
Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease. J Neurosci (2001) 1.52
Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res (1999) 1.48
Gastric bezoars: reassessment of clinical and radiographic findings in 19 patients. Br J Radiol (2009) 1.48
Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J Neurophysiol (1998) 1.46
Congenital esophageal stenosis in a 21-year-old man: clinical and radiographic findings. AJR Am J Roentgenol (1998) 1.42
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Undifferentiated (embryonal) sarcoma of the liver: pathologic basis of imaging findings in 28 cases. Radiology (1997) 1.40
Visualization of areae gastricae on double-contrast upper gastrointestinal radiography: relationship to age of patients. AJR Am J Roentgenol (2001) 1.39
Analysis of excess lung cancer risk in short-term employees. Am J Epidemiol (1988) 1.38
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol Dis (2005) 1.33
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience (2006) 1.32
The screw gene encodes a ubiquitously expressed member of the TGF-beta family required for specification of dorsal cell fates in the Drosophila embryo. Genes Dev (1994) 1.28
Meckel's enteroliths: clinical, radiologic, and pathologic findings. AJR Am J Roentgenol (1996) 1.27
Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest (1990) 1.25
Murine Hox-1.7 homeo-box gene: cloning, chromosomal location, and expression. Mol Cell Biol (1987) 1.23
Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol (2001) 1.21
Changes in apparent body orientation and sensory localization induced by vibration of postural muscles: vibratory myesthetic illusions. Aviat Space Environ Med (1979) 1.20
Splenic penetration by benign gastric ulcer: preoperative recognition with CT. Radiology (1987) 1.18
Modulatory actions of dopamine on NMDA receptor-mediated responses are reduced in D1A-deficient mutant mice. J Neurosci (1996) 1.17
Coiled-spring sign of appendiceal intussusception. Radiology (1985) 1.11
Diagnosis of primary versus secondary achalasia: reassessment of clinical and radiographic criteria. AJR Am J Roentgenol (2000) 1.11
Effect of a new thienodiazepine (We-941) on sleep patterns of normal and insomniac subjects. Neuropharmacology (1981) 1.10
Perirectal sinus tracks and fistulas caused by hidradenitis suppurativa. AJR Am J Roentgenol (2001) 1.10
Inverted Meckel diverticulum: clinical, radiologic, and pathologic findings. Radiology (1996) 1.07
Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices. Synapse (1996) 1.07
The patient with suspected small bowel obstruction: imaging strategies. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 1.07
Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms. J Neurosci (1995) 1.06
Radiologic recommendations in cases of gastric ulcer. CMAJ (1993) 1.06
Dopamine D4 receptor-deficient mice display cortical hyperexcitability. J Neurosci (2001) 1.06
Occupational allergy to laboratory animals: an epidemiologic study. J Occup Med (1986) 1.05
CtBP-dependent activities of the short-range Giant repressor in the Drosophila embryo. Proc Natl Acad Sci U S A (2001) 1.05
Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits. Dev Neurosci (2005) 1.04
Benign gastric ulcers: diagnosis and follow-up with double-contrast radiography. Radiology (1987) 1.04
Double-contrast barium enema examination technique. Radiology (2000) 1.03
Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex. Synapse (1992) 1.02
Occupational exposures to carbon monoxide in Baltimore firefighters. J Occup Med (1976) 1.02
Evaluation of patients with acute right upper quadrant pain. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 1.02
Delayed leaks and fistulas after esophagogastrectomy: radiologic evaluation. AJR Am J Roentgenol (1993) 1.01
Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein. Neuroscience (2009) 1.00
Infantile spasm-associated microencephaly in tuberous sclerosis complex and cortical dysplasia. Neurology (2007) 1.00
GABAergic basal forebrain neurons project to the neocortex: the localization of glutamic acid decarboxylase and choline acetyltransferase in feline corticopetal neurons. J Comp Neurol (1988) 0.99
Esophageal intramural pseudodiverticulosis: a reevaluation. AJR Am J Roentgenol (1986) 0.98
Multiple effects of serotonin on membrane properties of trigeminal motoneurons in vitro. J Neurophysiol (1997) 0.97
Duodenal gangliocytic paraganglioma: CT, MR imaging, and US findings. Radiology (1997) 0.96
Large colonic neoplasms missed by endoscopy. AJR Am J Roentgenol (1989) 0.96
Fire victims: medical outcomes and demographic characteristics. Am J Public Health (1977) 0.96
Candida esophagitis: accuracy of radiographic diagnosis. Radiology (1985) 0.95
Inhibition of esterase activity and an undercounting of circulating monocytes in a population of production workers. J Occup Med (1986) 0.95
Agonist-induced morphologic decrease in cellular D1A dopamine receptor staining. Synapse (1997) 0.95
Giant thoracic osteophyte causing esophageal food impaction. AJR Am J Roentgenol (1991) 0.95
Imaging evaluation of patients with acute abdominal pain and fever. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.95
Primary malignant melanoma of the esophagus: radiographic findings in seven patients. Radiology (1998) 0.94
Application of ILO classification to a population without industrial exposure: findings to be differentiated from pneumoconiosis. AJR Am J Roentgenol (1984) 0.94
Directional limits on persistent gravitational waves using LIGO S5 science data. Phys Rev Lett (2011) 0.93
The homeo box and mammalian development. Cell (1985) 0.93
CT findings in patients with esophagitis. AJR Am J Roentgenol (2000) 0.92
Persistent Na+ conductance in medium-sized neostriatal neurons: characterization using infrared videomicroscopy and whole cell patch-clamp recordings. J Neurophysiol (1995) 0.92
Punch shear testing of extracted vital and endodontically treated teeth. J Biomech (1983) 0.92
Is "intra-operating room" thromboelastometry useful in liver transplantation? A case-control study in 303 patients. Transplant Proc (2013) 0.91
Dye-coupling in the neostriatum of the rat: I. Modulation by dopamine-depleting lesions. Synapse (1989) 0.91
Cholesterol embolization as a cause of cecal infarct mimicking carcinoma. AJR Am J Roentgenol (1988) 0.91
Massive gastric distention due to duodenal involvement by retroperitoneal tumors. Gastrointest Radiol (1992) 0.91
Value of barium studies for predicting primary versus secondary non-Hodgkin's gastrointestinal lymphoma. Abdom Imaging (2000) 0.90
Omental cakes: colonic involvement by omental metastases. Radiology (1985) 0.90
Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci (1998) 0.90
Clinicians' and clients' perspectives on the impact of assertive community treatment. Psychiatr Serv (1999) 0.90
Radiographically diagnosed antral gastritis: findings in patients with and without Helicobacter pylori infection. Br J Radiol (2002) 0.89
Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A-deficient mouse. Neuroreport (1997) 0.89
Small-bowel enema in the diagnosis of adhesive obstructions. AJR Am J Roentgenol (1984) 0.89
Differences in heart rate and blood pressure in children with conduct disorder, major depression, and separation anxiety. Psychiatry Res (1990) 0.89
Carcinoma of the gastric cardia in young people. AJR Am J Roentgenol (1983) 0.89
Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia. Epilepsia (2000) 0.88
Postnatal development of glutamate receptor-mediated responses in the neostriatum. Dev Neurosci (1998) 0.88
Splenic implant in the jejunum: radiographic and pathologic findings. Abdom Imaging (1996) 0.88
Cerebral palsy diagnosis in children over age 1 year: standard criteria. Arch Phys Med Rehabil (1980) 0.87
Metastatic thyroid carcinoma presenting as an expansile intraluminal esophageal mass. Abdom Imaging (1995) 0.86
Radiographic findings and complications after surgical or endoscopic repair of Zenker's diverticulum in 16 patients. AJR Am J Roentgenol (2001) 0.86
Cytomegalovirus duodenitis in an AIDS patient. AJR Am J Roentgenol (1999) 0.86
Ileal endometriosis: radiographic findings in five cases. Radiology (2000) 0.86
Imaging of blunt abdominal trauma. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.85